You can buy or sell Histogenics and other stocks, options, ETFs, and crypto commission-free!
Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. Read More The company was founded on June 28, 2000 and is headquartered in Waltham, MA.
52 Week High
52 Week Low
Expected Nov 7, After Hours